Page last updated: 2024-09-04

olmesartan and Atheroma

olmesartan has been researched along with Atheroma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirohata, A; Ito, H; Komatsubara, I; Kusachi, S; Miyoshi, T; Murakami, T; Nakamura, K; Ohe, T; Usui, S; Yamamoto, K1
Miura, S; Saku, K1

Reviews

1 review(s) available for olmesartan and Atheroma

ArticleYear
Recent progress in the treatment of cardiovascular disease using olmesartan.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2014, Volume: 36, Issue:7

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Coronary Stenosis; Disease Models, Animal; Humans; Hypertension; Imidazoles; Plaque, Atherosclerotic; Tetrazoles

2014

Trials

1 trial(s) available for olmesartan and Atheroma

ArticleYear
Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial.
    Heart and vessels, 2014, Volume: 29, Issue:2

    Topics: Adiponectin; Aged; Angina, Stable; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Vessels; Disease Progression; Down-Regulation; Female; Humans; Imidazoles; Inflammation Mediators; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional

2014